Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Operating Expenses | 300 | 466 | 602 | 2,360 | 396 |
| Operating Income | -300 | -466 | -602 | -2,360 | -396 |
| Interest Expense | 1 | 11 | 2 | -10 | 57 |
| Other Income | 15 | 0 | 27 | -30 | 10 |
| Pre-tax Income | -286 | -477 | -577 | -2,380 | -443 |
| Net Income Continuous | -286 | -477 | -577 | -2,136 | -443 |
| Net Income Discontinuous | N/A | N/A | N/A | -229 | N/A |
| Net Income | $-279 | $-477 | $-577 | $-2,365 | $-443 |
| EPS Basic Total Ops | -0.40 | -0.80 | -0.16 | -3.60 | -0.80 |
| EPS Basic Continuous Ops | -0.41 | -0.80 | -0.17 | -3.25 | -0.80 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.35 | N/A |
| EPS Diluted Total Ops | -0.40 | -0.80 | -0.16 | -3.60 | -0.80 |
| EPS Diluted Continuous Ops | -0.41 | -0.80 | -0.17 | -3.25 | -0.80 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.35 | N/A |
| EBITDA(a) | $-300 | $-466 | $-602 | $-750 | $-400 |